Decreased expression of PER1 and PER3 in tumor tissue as such indicate poorer survival rate (178), decreased PER1 and high BMAL1 expression correlate with poorer outcome and liver metastasis (179), and high PER2 expression correlate with significantly better disease outcome (178). This evidence concerns the gene PER1 and neoplasm.